1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Breast Cancer Screening Market – By Test Type

1.3.2        Asia Pacific Breast Cancer Screening Market – By End User

1.3.3        Asia Pacific Breast Cancer Screening Market– By Region

2.           Breast Cancer Screening Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Breast Cancer Screening – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific

4.3         Expert Opinion

5.           Asia Pacific Breast Cancer Screening Market – Industry Dynamics

5.1         Key Drivers

5.1.1        Increasing Investments For Research in Breast Cancer Management

5.1.2        Growing Breast Cancer Prevalence Across Asia Pacific

5.2         Key Market Restraints

5.2.1        High Cost Associated With Breast Cancer Screening

5.3         Key Market Opportunities

5.3.1        Emerging Markets in Developing Countries

5.4         Future Trends

5.4.1        Agreements  And Collaborations For Diagnostic Solutions

5.5         Impact Analysis

6.           Breast Cancer Screening Market – Regional Analysis

6.1         Asia Pacific Breast Cancer Screening Market Revenue Forecast And Analysis

6.2         Market Positioning of Key Players

7.           Breast Cancer Screening Market Analysis –  By Test Type

7.1         Overview

7.2         Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)

7.2.1        Asia Pacific Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

7.3         Blood Marker Test

7.3.1        Overview

7.4         Blood Marker Tests: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Imaging Test

7.5.1        Overview

7.5.2        Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

7.6         Genetic Test

7.6.1        Overview

7.6.2        Genetic Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

7.7         Immunohistochemistry Test

7.7.1        Overview

7.7.2        Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.           Breast Cancer Screening Market – By End User

8.1         Overview

8.2         Breast Cancer Screening Market, by End User, 2019 and 2027 (%)

8.2.1        Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Diagnostics Centers

8.4.1        Overview

8.4.2        Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Research Laboratories

8.5.1        Overview

8.6         Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.7         Cancer Institutes

8.7.1        Overview

8.8         Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

9.           Breast Cancer Screening Market– Regional Analysis

9.1         Asia Pacific: Breast Cancer Screening Market

9.1.1        Overview

9.1.2        Asia Pacific: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        Asia Pacific: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.4        Asia Pacific: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.5        Asia Pacific: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)

9.1.6        China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          China: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.6.3          China: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.7        Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Japan: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.7.3          Japan: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.8        India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          India: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.8.3          India: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.9        South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1          South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2          South Korea: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.9.3          South Korea: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.10     Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1       Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2       Australia: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.10.3       Australia: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

10.        Impact of COVID-19 Pandemic On Asia Pacific Breast Cancer Screening Market

10.1      Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.        Breast Cancer Screening Market – Key Company Profiles

11.1      General Electric Company

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Siemens Healthineers AG

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Koninklijke Philips N.V.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Hologic, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      BD

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Myriad Genetics, Inc.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Danaher

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 3.             Asia Pacific Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)

Table 4.             Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 5.             China Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             China Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             Japan Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Japan Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 9.             IndiaBreast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          IndiaBreast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          South Korea Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          South Korea Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Australia Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Australia Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 15.          Glossary of Terms, Breast Cancer Screening Market

LIST OF FIGURES

Figure 1.           Breast Cancer Screening Market Segmentation

Figure 2.           Breast Cancer Screening Segmentation – By Region

Figure 3.           Asia Pacific Breast Cancer Screening Market Overview

Figure 4.           The Imaging Test Segment Held Largest Share Of Test Type Segment In Breast Cancer Screening Market

Figure 5.           India Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Asia Pacific PEST Analysis

Figure 7.           Breast Cancer Screening Market Impact Analysis Of Driver And Restraints

Figure 8.           Asia Pacific Breast Cancer Screening Market – Revenue Forecast And Analysis – 2019- 2027

Figure 9.           Market Positioning Of Key Players In Breast Cancer Screening Market

Figure 10.        Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)

Figure 11.        Blood Marker Tests: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Genetic Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Breast Cancer Screening Market, by End User, 2019 and 2027 (%)

Figure 16.        Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Asia Pacific: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)

Figure 21.        Asia Pacific Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)

Figure 22.        China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Impact of COVID-19 Pandemic In Asia Pacific Country Markets